Holen Sie sich die Stockscreener-App
6.15
5.49%
0.32
Schlusskurs vom Vortag:
$5.83
Offen:
$5.84
24-Stunden-Volumen:
8.28M
Relative Volume:
2.44
Marktkapitalisierung:
$1.49B
Einnahmen:
$386.15M
Nettoeinkommen (Verlust:
$-56.39M
KGV:
-26.74
EPS:
-0.23
Netto-Cashflow:
$-55.19M
1W Leistung:
+7.14%
1M Leistung:
+11.01%
6M Leistung:
+46.78%
1J Leistung:
+20.12%
1-Tages-Spanne:
$5.81
$6.3998
1-Wochen-Bereich:
$5.69
$6.3998
52-Wochen-Spanne:
$3.21
$6.78
Ardelyx Inc Stock (ARDX) Company Profile
Firmenname
Ardelyx Inc
Sektor
Branche
Telefon
510-745-7047
Adresse
34175 ARDENWOOD BLVD., FREMONT, CA
Vergleichen Sie ARDX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ARDX
Ardelyx Inc
|
6.15 | 1.42B | 386.15M | -56.39M | -55.19M | -0.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.13 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.31 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.17 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
839.99 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.12 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-03 | Fortgesetzt | Raymond James | Strong Buy |
| 2025-06-18 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-05-02 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2025-03-07 | Fortgesetzt | Ladenburg Thalmann | Buy |
| 2025-03-04 | Eingeleitet | BTIG Research | Buy |
| 2024-11-11 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-07-02 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-04-05 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-18 | Eingeleitet | Raymond James | Strong Buy |
| 2023-09-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-08-25 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2023-03-03 | Hochstufung | Wedbush | Neutral → Outperform |
| 2022-11-17 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-05-06 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-12-01 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2021-10-14 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2021-07-21 | Herabstufung | Jefferies | Buy → Hold |
| 2021-07-20 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-07-20 | Herabstufung | Wedbush | Outperform → Neutral |
| 2021-03-23 | Eingeleitet | Wedbush | Outperform |
| 2021-01-06 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-10-20 | Fortgesetzt | Citigroup | Buy |
| 2020-02-18 | Fortgesetzt | Jefferies | Buy |
| 2020-02-12 | Eingeleitet | Citigroup | Buy |
| 2020-02-10 | Eingeleitet | Cowen | Outperform |
| 2019-04-08 | Eingeleitet | Piper Jaffray | Overweight |
| 2018-08-24 | Eingeleitet | Jefferies | Buy |
| 2018-03-19 | Fortgesetzt | Leerink Partners | Outperform |
| 2017-11-29 | Bestätigt | Citigroup | Buy |
| 2017-11-22 | Bestätigt | Ladenburg Thalmann | Buy |
| 2017-10-17 | Fortgesetzt | Leerink Partners | Outperform |
| 2016-03-31 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2016-03-09 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2016-03-03 | Eingeleitet | Citigroup | Buy |
Alle ansehen
Ardelyx Inc Aktie (ARDX) Neueste Nachrichten
Ardelyx Shares Surge Following Strategic Clinical Update - timothysykes.com
Ardelyx Stock Rises Amid Market Developments - timothysykes.com
Raymond James reiterates Strong Buy on Ardelyx stock after price increases - Investing.com Nigeria
Ardelyx (ARDX) Boosts Product Prices, Shares Climb - GuruFocus
Ardelyx rises amid report on price hikes for lead product - MSN
Ardelyx stock jumps as Raymond James notes price hikes - Investing.com
Ardelyx stock jumps as Raymond James notes price hikes By Investing.com - Investing.com Australia
Ardelyx gains on price hikes for lead product (ARDX:NASDAQ) - Seeking Alpha
Jobs Data: Will Ardelyx Inc 41X stock outperform global peers2025 AllTime Highs & Expert Verified Movement Alerts - moha.gov.vn
Ardelyx Inc Stock Analysis and ForecastEarnings Growth Projections & Chat With Other Investors on Daily Signals - earlytimes.in
Ardelyx Insider Ups Holding By 19% During Year - Yahoo Finance
Trend Report: Why Ardelyx Inc stock is in analyst buy zoneQuarterly Investment Review & Reliable Intraday Trade Alerts - moha.gov.vn
Squarepoint Ops LLC Takes $708,000 Position in Ardelyx, Inc. $ARDX - MarketBeat
Do Ardelyx’s (ARDX) Leadership Changes Reframe How Investors View Its Long-Term Pipeline Strategy? - simplywall.st
Ardelyx, Inc. (NASDAQ:ARDX) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Ardelyx (ARDX): Revisiting Valuation After a Strong Multi‑Year Shareholder Return Run - simplywall.st
Market Wrap: Why The Gabelli Utility Trust Equity Right stock remains a top recommendationMarket Activity Report & Verified Stock Trade Ideas - moha.gov.vn
How Ardelyx Inc. stock compares to market leadersAnalyst Downgrade & Verified Chart Pattern Trade Signals - Улправда
How Ardelyx Inc. (41X) stock reacts to weak economy2025 Top Decliners & Low Risk High Win Rate Stock Picks - Улправда
How Ardelyx Inc. (41X) stock reacts to fiscal policiesJuly 2025 Volume & AI Enhanced Trading Alerts - Улправда
Aug Big Picture: Can Ardelyx Inc. stock hit analyst price targetsJuly 2025 Recap & Daily Oversold Bounce Ideas - Улправда
How resilient is Ardelyx Inc. stock in market downturnsJuly 2025 Momentum & Low Risk Growth Stock Ideas - Улправда
Can Ardelyx Inc. stock hit analyst price targetsJuly 2025 Opening Moves & Free Daily Entry Point Trade Alerts - Улправда
Ardelyx, Inc.'s (NASDAQ:ARDX) Institutional Investors Lost 8.5% Last Week but Have Benefitted From Longer-term Gains - 富途牛牛
Why Ardelyx Inc. stock is in analyst buy zone2025 Buyback Activity & Free Real-Time Market Sentiment Alerts - DonanımHaber
What analyst consensus says on Ardelyx Inc. stockTrade Signal Summary & Weekly Momentum Picks - DonanımHaber
Should I hold or sell Ardelyx Inc. stock in 20252025 Price Targets & Weekly High Potential Stock Alerts - Улправда
Ardelyx Announces Key Leadership Transitions - The Globe and Mail
Ardelyx announces executive departures and leadership transitions By Investing.com - Investing.com Canada
Ardelyx announces executive departures and leadership transitions - Investing.com
Ardelyx Inc. Reports Strong Q3 Earnings Growth - MSN
Ardelyx Announces Resignation of Chief Legal and Administrative Officer - TradingView — Track All Markets
Ardelyx (NASDAQ: ARDX) details C-suite resignations and 24-month advisory role - Stock Titan
Ardelyx (NASDAQ:ARDX) Trading Up 6.2%Still a Buy? - MarketBeat
Ardelyx, Inc.'s (NASDAQ:ARDX) Path To Profitability - simplywall.st
Ardelyx stock price target raised to $16 from $15 at Raymond James By Investing.com - Investing.com South Africa
Ardelyx stock price target raised to $16 from $15 at Raymond James - Investing.com Australia
Can Garware Hi Maintain Growth Without Diluting ShareholdersEarnings Forecast Updates & Minimal Investment Trading - earlytimes.in
Aug Swings: Will Ardelyx Inc stock benefit from AI adoptionTrade Volume Summary & Accurate Intraday Trading Signals - moha.gov.vn
Ardelyx, Inc.'s (NASDAQ:ARDX) Shift From Loss To Profit - Yahoo Finance
Marshall Wace LLP Raises Stock Position in Ardelyx, Inc. $ARDX - MarketBeat
Finanzdaten der Ardelyx Inc-Aktie (ARDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Ardelyx Inc-Aktie (ARDX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| RAAB MICHAEL | President & CEO |
Nov 21 '25 |
Sale |
5.54 |
46,887 |
259,609 |
1,455,363 |
| Kelliher Mike | See Remarks |
Nov 21 '25 |
Sale |
5.54 |
5,560 |
30,785 |
271,181 |
| Williams Laura A | Chief Patient Officer |
Nov 21 '25 |
Sale |
5.54 |
6,426 |
35,580 |
359,896 |
| Foster Eric Duane | Chief Commercial Officer |
Nov 21 '25 |
Sale |
5.54 |
5,814 |
32,192 |
295,684 |
| Reilly Joseph James | See Remarks |
Nov 21 '25 |
Sale |
5.54 |
11,086 |
61,382 |
108,914 |
0.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):